Biotechnology - Pharmaceutical, Management


Current filters:


Popular Filters

Exec appointments at Biogen Idec and Halozyme; Succession plan for Forest Labs


US biotech firm Biogen Idec (Nasdaq: BIIB) announced that Spyros Artavanis-Tsakonas, has been named chief…

Biogen IdecBiotechnologyForest LaboratoriesHalozyme TherapeuticsManagementPharmaceutical

US Senate confirms appointment of Marilyn Tavenner as CMS Administrator


US Health and Human Services (HHS) Secretary Kathleen Sebelius announced that the US Senate has confirmed…

BiotechnologyGenericsHealthcareManagementNorth AmericaPharmaceutical

Affymax slashes workforce following Omontys problems; evaluating options


US biopharma company Affymax (Nasdaq: AFFY) says that it will reduce its workforce as part of a plan…


Roche granted EU approval for Perjeta; board appointments


The European Medicines Agency has approved Swiss drug major Roche's (ROG: SIX) Perjeta (pertuzumab) for…


New US Federal Trade Commission chairman - Edith Ramirez - to be designated by President


President Barack Obama intends to designate Edith Ramirez as Chairman of the Federal Trade Commission…

BiotechnologyGenericsManagementNorth AmericaPharmaceuticalRegulation

Biopharma facing hiring difficulties and R&D talent gap, PwC unit finds


A talent gap in the scientific workforce has biopharmaceutical companies searching outside for fresh…

BiotechnologyManagementNorth AmericaPharmaceuticalResearch

Drugmakers spend an average $237,000 per medical science liaison in the USA


US-based drug companies spend an average $237,000 on each of their medical science liaisons (MSLs), but…

BiotechnologyGlobalManagementMarkets & MarketingPharmaceutical

The way forward in health care, by Gilbert Mertens


Preparing for a future of unseen opportunity in health care requires a profound shift in thinking from…


Patient adherence efforts gain more recognition throughout US pharma industry


Since 2009, US pharmaceutical companies have increased their patient adherence budgets by 281%, according…

BiotechnologyManagementMarkets & MarketingNorth AmericaPharmaceutical

Sanofi to cut 900 French research posts, a lot fewer than had been feared


French drug major Sanofi (Euronext: SAN) yesterday fleshed out on its plans for changes in its research…


Addressing the boardroom gender gap in life sciences industry


Nick Stephens, executive chairman of RSA, a global life sciences executive search and interim management…


Merck Serono creates second company under EPP


Merck Serono, a division of Germany's Merck KGaA (MRK: DE), has established Quartz Bio, the second spin-off…

BiotechnologyManagementMerck KGaAMerck SeronoPharmaceuticalQuartz Bio

Pharmaceutical sales rep access reducing most among oncologists in USA


As more pharmaceutical companies prepare to bring new oncology drugs to market, their sales representatives…

BiotechnologyManagementMarkets & MarketingNorth AmericaOncologyPharmaceutical

Dainippon Sumitomo to set up DSP Cancer Institute


Japanese drug major Dainippon Sumitomo Pharma (TYO: 4506) says it plans to establish a new organization…

BiotechnologyDainippon Sumitomo PharmaManagementOncologyPharmaceuticalResearch

Merck Serono sets up Prexton Therapeutics as first spin-off from its Entrepreneur Partnership Program


Merck Serono, a division of Germany's Merck KGaA (MRK: DE), has created Prexton Therapeutics, the first…

BiotechnologyLicensingManagementMerck KGaAMerck SeronoNeurologicalPharmaceuticalPrexton TherapeuticsResearch

New business model to relaunch the BioPharma industry, from ADL


Traditionally, clinical diagnoses and treatments have focused on diseases and cures. For every ailment,…

BiotechnologyManagementMarkets & MarketingPharmaceutical

Merck KGaA to rationalize operations in Switzerland


German drug major Merck KGaA (MRK: DE) has announced efficiency measures it plans to take related to…

BiotechnologyManagementMerck KGaAMerck SeronoPharmaceuticalResearch

Back to top